Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

UnitedHealth Group (NY: UNH )

466.42 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UnitedHealth Group

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
77 78 Next >
UNH: A Solid Healthcare Play In A Rotational Market
The blistering hot theme in markets right now is obviously the China trade, and this means investor capital is being allocated towards the Hang Seng, China ADRs, and for institutions that have access,... 
Via Talk Markets
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
Investors can find market-trouncing blue chip stocks in the healthcare industry. 
Via The Motley Fool
Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal
Blue Shield of California partners with Fresenius Kabi and Evio Pharmacy to cut the cost of Humira's biosimilar to $525 per month, with most members paying $0 out of pocket starting January 2025. 
Via Benzinga
UnitedHealthcare Commits $335,000 to Idaho Organizations To Expand Health Care Workforce and Access To Care
From UnitedHealthcare
Via Business Wire
Decoding UnitedHealth Group's Options Activity: What's the Big Picture?
Via Benzinga
Understanding UnitedHealth Group's Position In Health Care Providers &amp; Services Industry Compared To Competitors
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
Via Benzinga
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Stock-Split Watch: Is Microsoft Next?
Will Microsoft split its stock again? Here's why you shouldn't hold your breath waiting for that announcement. 
Via The Motley Fool
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
Humana Medicare Advantage plans are getting a big star-ratings cut. 
Via Investor's Business Daily
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017. 
Via Benzinga
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit. 
Via Benzinga
Spotlight on UnitedHealth Group: Analyzing the Surge in Options Activity
Via Benzinga
Comparing UnitedHealth Group With Industry Competitors In Health Care Providers &amp; Services Industry
Via Benzinga
What the Options Market Tells Us About UnitedHealth Group
Via Benzinga
These Were the 5 Biggest Companies in 2019, and Here Are the 5 Biggest Companies Now
The market leaders are benefiting from a long-term digital transformation across the economy to grow even bigger. 
Via The Motley Fool
Topics Economy
Exposures Economy
Got $1,000? 2 Unbelievable Growth Stocks to Buy and Hold Forever
These massive companies still have plenty of room to run. 
Via The Motley Fool
UNITEDHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating UnitedHealth Group Incorporated on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
3 Stocks Raising Dividends 4X Higher Than Inflation
Here are three stocks with a history of raising their dividend at more than 4x the rate of inflation and are likely to benefit from lower interest rates 
Via MarketBeat
Topics Economy
Exposures Interest Rates
If You Invested $100 In This Stock 10 Years Ago, You Would Have $700 Today
Via Benzinga
What the Options Market Tells Us About UnitedHealth Group
Via Benzinga
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. 
Via MarketBeat
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
The FTC is going after these PBMs. Is this an opportunity for investors? 
Via The Motley Fool
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
3 Top Large Cap Stocks For A Stable Approach: ETN, DECK, UNH
For those seeking large-cap exposure, these three stocks have all seen their near-term outlooks shift positively. Let’s take a closer look at each. 
Via Talk Markets
UNITEDHEALTH GROUP INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of UnitedHealth Group Incorporated - UNH
From Kahn Swick & Foti, LLC
Via Business Wire
UnitedHealth Group Announces Earnings Release Date
From UnitedHealth Group
Via Business Wire
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
77 78 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.